Last updated 2026-07-20
- Went public on TASE (EPIT), Dec 2021
- Raised $51M Follow-on PO led by XT Hi-tech, Dec 2021
- Raised $8M Series B led by XT Venture Capital, Apr 2019
Total raised
$68.0M
Last: Public Offering 2021-12
Stage
Public
Founded
2005
Headcount
44
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
Epitomee Medical is a public company developing and commercializing ingestible therapeutic devices. Their groundbreaking platform technology is based on self-expanding hydro-gel scaffolds folded into a standard pharmaceutical capsule, produced from biocompatible excipients, food additives, and food contact materials. These hydro-gel scaffolds can be engineered to be triggered by different zone-specific pH levels, allowing for optimal therapeutic effect. The company is advancing two major fields: weight management and biologic drug delivery. Their flagship product is an FDA-cleared and CE-marked ingestible capsule for weight management that expands in the stomach to create a feeling of fullness.
Funding history · 4 rounds · $68.0M total
2021-12
Follow-on PO
$51.0M
★ XT Hi-tech★ Barak Capital★ Leumi Partners★ Nestlé Health Science★ Leumi Partners Underwritingcompanies related to Udi Angelcompanies related to Idan Ofer
2019-04
B Round
$8.0M
★ XT Venture CapitalGCBXT Hi-TechDr. Shimon Eckhouse
2008-08
A Round
$8.0M
★ 7 Health Ventures★ Canadian investors★ Dr. Shimon Eckhouse★ Agate Medical Investments
1969-12
Seed
$1.0M
Headcount over time
From 14 (2019-03) to 33 (2025-12) · +19 (+136%) · 10 points · source: Finder history + radar grounding
Q&A
- What is Epitomee Medical's primary focus?
- Epitomee Medical develops and commercializes ingestible therapeutic devices, specifically drug-free capsules for diabetes prevention and weight loss.
- When did Epitomee Medical go public and on what exchange?
- Epitomee Medical went public on the TASE in December 2021, raising $51,000,000 with a valuation of $200,000,000.
- What was a significant recent regulatory achievement for Epitomee Medical?
- In September 2024, Epitomee Medical announced that the United States Food and Drug Administration (FDA) officially cleared its Epitomee® capsule weight management device.
- What was the outcome of Epitomee Medical's partnership with Nestlé Health Science?
- Epitomee Medical and Nestlé Health Science announced a partnership for the development and commercialization of the Epitomee weight loss capsule in August 2020. However, in November 2023, Nestlé canceled the agreement, causing Epitomee's stock to decline.
- What is the current employee count for Epitomee Medical?
- Epitomee Medical has 44 employees, falling within the 11-50 employee bucket.
- What is Epitomee Medical's current market capitalization?
- Epitomee Medical's market capitalization is $56,997,985.
- What is the status of Epitomee Medical's weight loss capsule in Europe?
- In March 2026, Epitomee Medical's slimming pill was approved in Europe, and the company has a distribution agreement with a German company, with sales already initiated in Israel.
Team · 2
Shimon Eckhouse
Founder · Co-Founder and Chairman of the Board
Doron Marco
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsConsumersRecreational & Lifestyle
Business model
B2CB2B2C
Highlights
1 PatentsVerified
Tags
medical-devicesoral-drugsmedical-productsgastroenterologynon-surgicalobesitydiabetesconsumerswellness
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
Identifiers & details
| Former names | Tulip Medical |
|---|---|
| Founded | 2005-8 |
| Employees (exact) | 44 |
| Market cap | $57.0M |
| Status reason | Public on TASE on Dec, 2021; |
| Wikidata QID | Q110088556 |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2021-12 | TASE | EPIT | $51.0M |
Radar intelligence
Patents
| EPO | 7 |
|---|
Web history (Wayback)
| Domain | epitomeemedical.com |
|---|
Wikidata
| QID | Q110088556 |
|---|
Certificate / subdomain footprint
| Subdomains | 17 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513721803 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2005-08-15 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2017 |
| Active charges / liens | 1 |
| Registry events | 1 — charge (1) |
| Registered address | הטוחן 17 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-14 | רישום שעבוד |